Local Therapy Indications in the Management of Patients with Oligometastatic Non-Small Cell Lung Cancer

Douglas A Miller; Mark J Krasna

doi:10.1016/j.soc.2016.02.007

Local Therapy Indications in the Management of Patients with Oligometastatic Non-Small Cell Lung Cancer

Surg Oncol Clin N Am. 2016 Jul;25(3):611-20. doi: 10.1016/j.soc.2016.02.007.

Authors

Douglas A Miller¹, Mark J Krasna²

Affiliations

¹ Jersey Shore University Medical Center, Neptune, NJ 07753, USA. Electronic address: DMiller@meridianhealth.com.
² Jersey Shore University Medical Center, Neptune, NJ 07753, USA.

PMID: 27261919
DOI: 10.1016/j.soc.2016.02.007

Abstract

Advances in surgical, radiation, and interventional radiology therapies carry a reduction in morbidity associated with therapy. Aggressive management of patients with oligometastatic non-small cell lung cancer offers the potential for improved disease-free survival and quality of life compared with traditional systemic therapy alone.

Keywords: Intracranial radiosurgery; Oligometastatic lung cancer; Stereotactic ablative radiotherapy (SABR).

Publication types

Review

MeSH terms

Carcinoma, Non-Small-Cell Lung / pathology*
Carcinoma, Non-Small-Cell Lung / therapy
Disease-Free Survival
Humans
Lung Neoplasms / pathology*
Lung Neoplasms / therapy
Neoplasm Metastasis
Quality of Life*
Radiosurgery
Treatment Outcome